Director Gagnon Robert E. sold Verastem Inc. ($VSTM) shares on the open market four times over the past year, for a total of nearly $9,000. His most recent sale occurred on December 16, 2025. These transactions rank 11,293rd among 11,678 individual insiders, well below the average sale value of $8.6 million across 6.4 transactions. Gagnon made no open market purchases of $VSTM in the last 365 days.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 22, 2026 | Opus Genetics, Inc. | $IRD | Gagnon Robert E. | Chief Financial Officer | A | Common Stock | 400000 | $0.00 | 600,000.0000 | 70,636,887 | 200.00% | 0.57% |
| Dec. 16, 2025 | Verastem, Inc. | $VSTM | Gagnon Robert E. | Director | S | Common Stock | 283 | $9.14 | 41,678.0000 | 73,157,000 | 0.67% | 0.00% |
| Sept. 16, 2025 | Verastem, Inc. | $VSTM | Gagnon Robert E. | Director | S | Common Stock | 281 | $9.99 | 41,961.0000 | 74,037,000 | 0.67% | 0.00% |
| Sept. 10, 2025 | Opus Genetics, Inc. | $IRD | Gagnon Robert E. | Chief Financial Officer | A | Common Stock | 200000 | $0.00 | 200,000.0000 | 26,715,526 | 9999.99% | 0.75% |
| Sept. 2, 2025 | Opus Genetics, Inc. | $IRD | Gagnon Robert E. | Chief Financial Officer | A | Employee Stock Option (right to buy) | 250000 | $0.00 | 250,000.0000 | 26,715,526 | 9999.99% | 0.94% |
| July 16, 2025 | HARVARD BIOSCIENCE INC | $HBIO | Gagnon Robert E. | Director | A | Common Stock | 110000 | $0.00 | 110,000.0000 | 44,074,475 | 9999.99% | 0.25% |
| June 16, 2025 | Verastem, Inc. | $VSTM | Gagnon Robert E. | Director | S | Common Stock | 284 | $5.65 | 42,242.0000 | 54,173,000 | 0.67% | 0.00% |
| June 4, 2025 | Bone Biologics Corp | $BBLG | Gagnon Robert E. | Director | A | Non-Employee Stock Option | 62894 | $0.00 | 101,622.0000 | 3,271,042 | 162.40% | 1.92% |
| May 22, 2025 | Verastem, Inc. | $VSTM | Gagnon Robert E. | Director | A | Stock Option (right to buy) | 12500 | $0.00 | 12,500.0000 | 54,173,000 | 9999.99% | 0.02% |
| May 22, 2025 | Verastem, Inc. | $VSTM | Gagnon Robert E. | Director | A | Common Stock | 8333 | $0.00 | 42,526.0000 | 54,173,000 | 24.37% | 0.02% |
| March 17, 2025 | Verastem, Inc. | $VSTM | Gagnon Robert E. | Director | S | Common Stock | 284 | $6.95 | 34,193.0000 | 35,713,000 | 0.82% | 0.00% |
| Dec. 16, 2024 | Verastem, Inc. | $VSTM | Gagnon Robert E. | Director | S | Common Stock | 285 | $4.54 | 34,607.0000 | 40,258,000 | 0.82% | 0.00% |
| Dec. 19, 2024 | Verastem, Inc. | $VSTM | Gagnon Robert E. | Director | S | Common Stock | 130 | $4.37 | 34,477.0000 | 40,258,000 | 0.38% | 0.00% |
| Sept. 19, 2024 | Verastem, Inc. | $VSTM | Gagnon Robert E. | Director | S | Common Stock | 131 | $2.79 | 34,892.0000 | 26,861,000 | 0.37% | 0.00% |
| Sept. 17, 2024 | Bone Biologics Corp | $BBLG | Gagnon Robert E. | Director | A | Non- Employee Stock Option | 30713 | $0.00 | 38,728.0000 | 0 | 383.19% | 0.00% |
| Sept. 16, 2024 | Verastem, Inc. | $VSTM | Gagnon Robert E. | Director | S | Common Stock | 287 | $2.80 | 35,023.0000 | 26,861,000 | 0.81% | 0.00% |
| June 18, 2024 | Verastem, Inc. | $VSTM | Gagnon Robert E. | Director | A | Stock Option (right to buy) | 12500 | $0.00 | 12,500.0000 | 26,832,000 | 9999.99% | 0.05% |
| June 20, 2024 | Verastem, Inc. | $VSTM | Gagnon Robert E. | Director | S | Common Stock | 131 | $3.21 | 35,310.0000 | 26,832,000 | 0.37% | 0.00% |
| June 18, 2024 | Verastem, Inc. | $VSTM | Gagnon Robert E. | Director | A | Common Stock | 8333 | $0.00 | 35,441.0000 | 26,832,000 | 30.74% | 0.03% |
| June 17, 2024 | Verastem, Inc. | $VSTM | Gagnon Robert E. | Director | S | Common Stock | 283 | $3.49 | 27,108.0000 | 26,832,000 | 1.03% | 0.00% |
| March 18, 2024 | Verastem, Inc. | $VSTM | Gagnon Robert E. | Director | S | Common Stock | 283 | $10.71 | 27,521.0000 | 22,054,000 | 1.02% | 0.00% |
| March 19, 2024 | Verastem, Inc. | $VSTM | Gagnon Robert E. | Director | S | Common Stock | 130 | $10.38 | 27,391.0000 | 22,054,000 | 0.47% | 0.00% |
| Feb. 6, 2024 | Verastem, Inc. | $VSTM | Gagnon Robert E. | Director | S | Common Stock | 9204 | $13.70 | 27,804.0000 | 22,054,000 | 24.87% | 0.04% |
| Jan. 12, 2024 | Verastem, Inc. | $VSTM | Gagnon Robert E. | Director | S | Common Stock | 9204 | $10.95 | 37,008.0000 | 22,054,000 | 19.92% | 0.04% |
| Jan. 8, 2024 | Bone Biologics Corp | $BBLG | Gagnon Robert E. | Director | A | Non-Employee Stock Option | 9 | $0.00 | 9.0000 | 0 | 9999.99% | 0.00% |
| Jan. 8, 2024 | Bone Biologics Corp | $BBLG | Gagnon Robert E. | Director | A | Non-Employee Stock Option | 8 | $0.00 | 8,015.0000 | 0 | 0.10% | 0.00% |